跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,397 条关于
“Nivoluma”
全部
2,397
临床试验
1,794
药物
28
机构
1
资讯
574
2个月前
Bangladesh Drug Pricing Deadlock Stalls Hundreds of New Medicines, Threatens Industry Innovation
2年前
Advancements in NSCLC Treatment: Novel Immunotherapy Combinations and Perioperative Strategies Show Promise
去年
CheckMate 77T Trial Shows Perioperative Nivolumab Preserves Quality of Life in Resectable NSCLC
2年前
Short-Term Immunotherapy Shows Promise in Early-Stage TNBC Treatment
去年
Nivolumab Recommended for Approval in India for Urothelial Carcinoma
2年前
Nivolumab Plus Ipilimumab Improves Quality of Life in MSI-H/dMMR Metastatic Colorectal Cancer
2年前
Perioperative Nivolumab Demonstrates Significant EFS Benefit in Resectable NSCLC
去年
Nivolumab Access Improved for Adolescents with Hodgkin Lymphoma Through Lowered Clinical Trial Age Restrictions
去年
Ipilimumab and Nivolumab Show Promise in Higher-Risk Myelodysplastic Syndromes
去年
Adjuvant Nivolumab Shows Sustained Benefit in High-Risk Urothelial Carcinoma
第 1 页,共 58 页
上一页
下一页